The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sadikot, R. T.
Right arrow Articles by Christman, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sadikot, R. T.
Right arrow Articles by Christman, J. W.
The Journal of Immunology, 2004, 172: 1801-1808.
Copyright © 2004 by The American Association of Immunologists

p47phox Deficiency Impairs NF-{kappa}B Activation and Host Defense in Pseudomonas Pneumonia1

Ruxana T. Sadikot2,*, Heng Zeng*, Fiona E. Yull{dagger}, Bo Li*, Dong-sheng Cheng*, Douglas S. Kernodle{ddagger}, E. Duco Jansen§, Christopher H. Contag, Brahm H. Segal||, Steven M. Holland||, Timothy S. Blackwell* and John W. Christman*

* Department of Veterans Affairs and Division of Allergy, Pulmonary and Critical Care, {dagger} Department of Cancer Biology, {ddagger} Division of Infectious Diseases, and § Department of Biomedical Engineering, Vanderbilt University School of Medicine, Nashville, TN 37232; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305; and || Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We examined the role of redox signaling generated by NADPH oxidase in activation of NF-{kappa}B and host defense against Pseudomonas aeruginosa pneumonia. Using mice with an NF-{kappa}B-driven luciferase reporter construct (HIV-LTR/luciferase (HLL)), we found that intratracheal administration of P. aeruginosa resulted in a dose-dependent neutrophilic influx and activation of NF-{kappa}B. To determine the effects of reactive oxygen species generated by the NADPH oxidase system on activation of NF-{kappa}B, we crossbred mice deficient in p47phox with NF-{kappa}B reporter mice (p47phox-/-HLL). These p47phox-/-HLL mice were unable to activate NF-{kappa}B to the same degree as HLL mice with intact NADPH oxidase following P. aeruginosa infection. In addition, lung TNF-{alpha} levels were significantly lower in p47phox-/-HLL mice compared with HLL mice. Bacterial clearance was impaired in p47phox-/-HLL mice. In vitro studies using bone marrow-derived macrophages showed that Toll-like receptor 4 was necessary for NF-{kappa}B activation following treatment with P. aeruginosa. Additional studies with macrophages from p47phox-/- mice confirmed that redox signaling was necessary for maximal Toll-like receptor 4-dependent NF-{kappa}B activation in this model. These data indicate that the NADPH oxidase-dependent respiratory burst stimulated by Pseudomonas infection contributes to host defense by modulating redox-dependent signaling through the NF-{kappa}B pathway.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Pseudomonas aeruginosa is an opportunistic pathogen that causes disease in patients with impaired host defense and is often a cause of life-threatening nosocomial infection in critically ill mechanically ventilated patients (1). The mechanisms that regulate innate immune response in P. aeruginosa pneumonia are not completely defined, and a better understanding of host defense factors could result in novel treatments directed toward augmenting the host response. The pathogenesis of Pseudomonas infection involves a complex interaction between virulence factors of the microbe and host immunity. Multiple factors collectively contribute to the host response against P. aeruginosa (2). The first line of innate immune defenses, including the mucosal barrier and mucociliary escalator, is breached in patients with endotracheal intubation. Host defense in these mechanically ventilated patients involves resident macrophages and recruitment of neutrophils to the site of infection.

Vital functions of phagocytic cells include microbicidal and signaling capabilities. Microbicidal effects are thought to be mediated primarily by the generation of reactive oxygen species (ROS)3 and reactive nitrogen species, although they may play a stronger signaling role than previously suspected. Intracellular signaling is critical in facilitating the shift from resting state to an activated state upon encounter with a microbe. Following exposure to bacterial components, activation of NF-{kappa}B via Toll-like receptors (TLRs) is required in macrophages and other cell types to synthesize protein mediators that are critical for host defense (3, 4).

NADPH oxidase is a multicomponent enzyme localized in the plasma membrane of phagocytic leukocytes and is a major oxidant-generating enzyme. It accepts electrons from NADPH and donates these to molecular oxygen to produce superoxide (5). In recent years, it has been increasingly evident that ROS serve as second messengers and activate signaling pathways that result in a broad array of physiological responses that range from cell proliferation to gene expression and apoptosis (6, 7). It is possible that the free radicals generated by NADPH oxidase contribute to host defenses not only through their microbicidal action but also through modulation of redox-sensitive pathways in phagocytes.

NF-{kappa}B is an important intracellular signaling pathway for both innate and acquired immunity. The NF-{kappa}B family of transcription factors impacts host defense against infectious agents by inducing the expression of inflammatory genes. Target genes that are transcriptionally regulated by NF-{kappa}B and play an important role in host defense include the following: 1) proinflammatory cytokines such as TNF-{alpha} and IL-1{beta}, 2) chemokines such as KC and macrophage-inflammatory protein (MIP)-2, and 3) enzymes such as inducible NO synthase and cyclooxygenase-2, and 4) {beta}-defensins (8, 9, 10). Activation of NF-{kappa}B can be initiated by many stimuli including bacterial components such as LPS from Gram-negative bacteria and host-derived products such as TNF-{alpha}, IL-1{beta}, and ROS (8, 9).

The purpose of the present study was to investigate regulation of the NF-{kappa}B pathway in a model of Pseudomonas pneumonia, particularly the role of ROS generated by the NADPH oxidase system. In these studies, we used a transgenic mouse model to quantitatively evaluate NF-{kappa}B-dependent transcriptional activity. We have developed a transgenic reporter mouse model that possesses the HIV long terminal repeat (LTR) driving the expression of Photinus luciferase cDNA (referred to as HIV-LTR/luciferase (HLL) mice) luciferase reporter mice (HLL) (11, 12). To examine the effects of NADPH oxidase products on NF-{kappa}B activation in vivo, we crossbred p47phox-deficient mice with HLL mice (p47phox-/-HLL). We used in vivo bioluminescent imaging (BLI) to assess the levels of luciferase expression from the reporter transgenes or bacterial load in living animals (13, 14). Because the NADPH oxidase system functions primarily in phagocytes, and macrophages are important for host defense, we performed in vitro studies using bone marrow-derived macrophages (BMDM). In these studies, we investigated whether Pseudomonas interacts with TLR4 to mediate NF-{kappa}B activation and whether NADPH oxidase impacts activation of NF-{kappa}B via a TLR4-dependent pathway.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animal model

HLL transgenic and p47phox-/-HLL mice express Photinus luciferase cDNA under the control of proximal 5' HIV-LTR promoter, and the mice are on C57B6/DBA background. Mice weighing 20–30 g were used (15). After sedation with ketamine/xylazine, mice were treated with intratracheal (IT) administration of P. aeruginosa (strain PA103) or XEN-5 (see strain descriptions below). Mouse tracheas were directly exposed by surgical resection, pierced with a 26-gauge needle, and injected with 100 µl of bacterial inoculum preparation diluted in sterile PBS. The neck wound was closed with sterile sutures under aseptic conditions.

Mice were asphyxiated with CO2. Lungs were removed; one lung was ground in 1 ml of reporter lysis buffer (Promega, Madison, WI) and stored at -20°C for luciferase assays, and the other lung was frozen at -70°C. Where indicated, tracheas were cannulated, and lungs were lavaged in situ with sterile pyrogen-free physiological saline that was instilled in four 1-ml aliquots and gently withdrawn with a 1-ml tuberculin syringe.

P. aeruginosa PA103

This strain was selected because it is a well-characterized and highly toxic strain. Bacteria from frozen stocks were streaked onto trypticase soy agar plates and grown in a dialysate of tripticase soy broth supplemented with 10 mM nitrilotriacetic acid (Sigma-Aldrich, St. Louis MO), 1% glycerol, and 100 mM monosodium glutamate at 33°C for 1–3 h in a shaking incubator. Cultures were centrifuged at 8500 x g for 5 min, and the bacterial pellet was washed twice in Ringers lactate and diluted into the appropriate number of CFU per milliliter in Ringers lactate solution determined by spectrophotometer. The concentration of bacteria was confirmed by serial dilutions plated on sheep blood agar.

P. aeruginosa XEN-5

To visualize the extent of the bacterial load in vivo, we used P. aeruginosa expressing the lux operon, luxCDABE (bioluminescence genes), from the nematode symbiont bacterium Photorhabdus luminescens (previously known as Xenorhabdus luminescens). This strain was obtained from Xenogen (Almeda, CA) (16).

In vivo measurement of luciferase gene expression by bioluminescence

HLL and p47phox-/-HLL mice were anesthetized, and the hair was removed over the chest and abdomen before imaging. Luciferin (150 mg/kg/mouse in 200 µl of isotonic saline) was administered by i.p. injection, and mice were imaged with an intensified charge-coupled device camera (model no. C2400-32; Hamamatsu, Bridgewater, NJ). For the duration of photon counting (3 min), mice were placed inside a light-tight box. Light emission from the mouse was detected as photon counts using the intensified charge-coupled device camera and customized image processing hardware and software (Hamamatsu) and expressed as photon counts. A digital false-color photon emission image of the mouse was generated, and photons were counted over a standard region of interest corresponding to the area of the chest overlying the midlung zone. Images were obtained before and following treatment with bacteria so that each mouse could be used as its own control (17). Bioluminescence of the XEN-5 bacteria was assessed similarly in separate mice that were not treated with luciferin before imaging. The five-gene operon from P. luminescens includes genes that encode enzymes for the biosynthesis of the substrate, decanal, hence exogenous addition of substrate is not required for light emission (18).

Measurement of luciferase activity in lung tissue

Luciferase activity was measured in postmortem tissue samples by adding 100 µl of freshly reconstituted luciferase assay buffer to 20 µl of the homogenated lung tissue that was ground in reporter lysis buffer (Promega). Luciferase activity was expressed as relative light units normalized for protein content, which was measured by Bradford assay (19).

Lung lavage total and differential cell counts

Lung lavage fluid was centrifuged at 400 x g for 10 min to separate cells from supernatant. Supernatant was saved separately and frozen at -70°C. The cell pellet was suspended in serum-free RPMI 1640 culture medium, and total cell counts were determined on a grid hemocytometer. Differential cell counts were determined by staining cytocentrifuge slides with a modified Wright stain (Diff-Quik; Baxter, McGraw Park, IL) and counting 400–600 cells in complete cross sections.

TNF-{alpha} and MIP-2 ELISA

TNF-{alpha} and MIP-2 levels were measured using a sandwich ELISA according to the manufacturer’s instructions (R&D Systems, Minneapolis, MN).

Extraction of nuclear proteins from tissue samples

Tissue nuclear proteins were extracted from whole-lung tissue by the method of Deryckere and Gannon (20). Briefly, 50–100 mg of tissue was mechanically homogenized in liquid nitrogen, to which 4 ml of buffer A (150 mM NaCl, 10 mM HEPES (pH 7.9), 0.6% (v/v) Nonidet P-40, 0.2 M EDTA, and 0.1 M PMSF) was added. The homogenate was transferred to a 15-ml Falcon tube and centrifuged at 850 x g in a tabletop centrifuge for 30 s to remove cellular debris. The supernatant was then transferred to a 50-ml Falcon tube and incubated on ice for 5 min before being centrifuged for 10 min at 3500 x g. Supernatant was collected as a cytoplasmic extract. The pellet was resuspended in 300 µl of buffer B (sterile water, 25% (v/v) glycerol, 20 mM HEPES (pH 7.9), 5 M NaCl, 1 M MgCl2, 0.2 M EDTA, 0.1 M phenylsulfonyl fluoride, 1 M DTT, 10 mg/ml benzamidine, 1 mg/ml pepstatin, 1 mg/ml leupeptin, and 1 mg/ml aprotonin) and incubated on ice for 30 min. Following centrifugation at 14,000 rpm in an Eppendorf microcentrifuge for 2 min, the supernatant was collected as the nuclear extract and frozen at -70°C. Protein concentrations in nuclear extracts were determined by using Bradford assay (19).

Western blot for RelA in nuclear protein extracts

Twenty-five micrograms of protein from tissue homogenates were separated on a 10% acrylamide gel, transblotted, and immunodetected. Abs to RelA were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).

Bacterial clearance studies

Before harvesting the lungs, the right ventricle was infused with 1 ml of sterile PBS to remove blood from the lung tissue. The lungs were removed aseptically and placed in 3 ml of sterile saline. Lungs were homogenized in a tissue homogenizer under sterile conditions. Serial dilutions of the homogenates were made, and 10 µl of each dilution was plated in soy base blood agar plates that were incubated for 18 h at 37°C, and then number of colonies was counted.

BMDM

After asphyxiation of mice with CO2, cellular material from femurs was aspirated and spun at 400 x g at 4°C for 5 min. Cells were then resuspended in DMEM with 10% FBS and 10% L929 cell-conditioned medium. Cells were allowed to mature into phenotypic macrophages by incubation in the presence of L929 cell-conditioned medium for 5 days. Cells were lifted, washed, counted, and replated before study.

Superoxide measurements

Superoxide production was measured from BMDM after treatment with P. aeruginosa using a commercially available Lumimax superoxide kit from Stratagene (La Jolla, CA).

Statistical analysis

Our statistical analyses were performed with GraphPad InStat, version 3.01 for Windows NT (GraphPad Software, San Diego, CA), using an unpaired t test and unpaired ANOVA.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
P. aeruginosa lung infection induces a dose-dependent activation of NF-{kappa}B and neutrophilic influx in the lungs

We first performed experiments to assess NF-{kappa}B activation after P. aeruginosa infection. HLL mice were treated by a single IT injection of PA103 P. aeruginosa in a dose of 1 x 106 CFU diluted in 100 µl of PBS. Control mice were treated with 100 µl of pyrogen-free PBS by IT injection. BLI was used to detect luciferase activity in vivo as a reflection of the intensity of NF-{kappa}B activation in these reporter transgenic mice. Mice were treated with luciferin by the i.p. route and imaged at 24, 48, and 72 h postinfection. Control mice treated with PBS showed no increase in bioluminescent signal intensity, but mice treated with IT P. aeruginosa (106 CFU) showed increased photon emission from a standardized region of the thorax (photon counts (mean ± SEM): baseline, 950 ± 349; 24 h, 3908 ± 421; 48 h, 2961 ± 511; and 72 h, 2443 ± 384). Because peak luciferase activity occurred at 24 h, we harvested mice at this time point for dose-response experiments. Fig. 1 shows representative images of HLL mice treated with PBS or PA103 (105, 106, and 107 CFU) at 24 h. The computer software generates a false-color image that reflects the intensity of photon emission (blue is less intense, and white is most intense). To visualize the dimmer parts of the image, the brighter pixels in the images are displayed as white (thus appearing saturated); however, the detected light emission is well below the saturation limit of the camera. These images illustrate a dose-dependent increase in bioluminescence over the chest after treatment with PA103. In these studies, three of the seven mice treated with a dose of 1 x 107 CFU died. Hence, additional experiments were performed with a sublethal dose of 1 x 106 CFU.



View larger version (78K):
[in this window]
[in a new window]
 
FIGURE 1. Imaging of gene expression in HLL mice. A–D, To reveal NF-{kappa}B activation patterns, representative bioluminescent images are shown at baseline (A) or 24 h after IT injection of P. aeruginosa at 105 (B), 106 (C), or 107 (D) CFU. Increases in photon emission over the chest, indicative of NF-{kappa}B activation in the lung, correspond to increases in the size of P. aeruginosa inocula. The scale for the pseudocolor images, indicative of relative light intensity, is shown at left (white is the highest color). E, Luciferase activity was determined in homogenates of lung tissue from HLL mice at baseline and 24 h after treatment with P. aeruginosa at doses of 105, 106, and 107 CFU/ml. *, p < 0.05 compared with untreated control. Mean ± SEM, n = 4 per group.

 
In subsequent experiments, mice were sacrificed at 24 h after treatment with 1 x 106 CFU of PA103. Bronchoalveolar lavage (BAL) was performed, and luciferase activity was measured from lung homogenates. Luciferase activity in the lungs measured by conventional luminometer showed an increase in mean counts with higher doses (Fig. 1E) that mirrored the bioluminescence images (A–D). Total cell and neutrophil counts from BAL showed increases in mean counts with higher doses, although there was no statistically significant difference in the three groups (Fig. 2). These data indicate that P. aeruginosa pneumonia is associated with intense activation of NF-{kappa}B and neutrophil influx into the lungs.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 2. Total neutrophils counts in BAL of HLL mice at 24 h after treatment with P. aeruginosa reveal increasing cell numbers with increasing inoculum sizes. *, p < 0.05 compared with untreated control; n = 4 per group.

 
p47phox-deficient mice showed decreased NF-{kappa}B activation and impaired bacterial clearance from the lungs

To examine the effects of ROS from NADPH oxidase on NF-{kappa}B activation in vivo, HLL mice were crossbred with p47phox-/- mice (p47phox-/-HLL). p47phox-/-HLL mice or HLL mice were treated with P. aeruginosa (106 CFU). Control animals from both groups were treated with pyrogen-free PBS. The p47phox-/-HLL mice showed lower luciferase activity at 24 h compared with the HLL mice as measured by BLI (Fig. 3A). The peak photonic counts were significantly lower in p47phox-/- mice (1400 ± 230; n = 6) compared with HLL mice (3250 ± 370; n = 6; p < 0.005). After imaging, mice were harvested at 24 h, and luciferase activity from lung homogenates confirmed that production of the NF-{kappa}B-dependent reporter expression was lower in infected p47phox-/-HLL mice than HLL mice (Fig. 3B). Analysis of the cellularity of BAL showed no statistically significant difference in the total and neutrophil counts between the p47phox-/-HLL (34 x 105) and HLL mice (6 x 105), although the p47phox-/-HLL mice showed a trend toward higher neutrophil counts. MIP-2 was measured in the BAL, because it is an NF-{kappa}B-dependent chemokine that is important for neutrophil recruitment. MIP-2 levels in BAL closely paralleled the neutrophil counts, and there was no statistically significant difference between the two groups of mice (data not shown).



View larger version (62K):
[in this window]
[in a new window]
 
FIGURE 3. A, BLI of HLL and p47phox-/- mice 24 h after infection with Pseudomonas (106 CFU/ml). The p47phox-/- mouse shows lower luciferase activity over the chest. B, Lung luciferase assays measured by luminometer from lung homogenates of HLL and p47phox-/-HLL mice at 24 h after Pseudomonas infection (normalized for total protein). *, p < 0.05 compared with p47phox-/-HLL. Mean ± SEM, n = 6 per group.

 
In addition to luciferase, NF-{kappa}B activation was detected by performing Western blot analysis for RelA from lung nuclear protein extracts. HLL mice showed greater amounts of RelA in the nuclear extracts compared with the p47phox-/-HLL mice both at 12 and 24 h (Fig. 4, A and B). Analysis by densitometry of the RelA bands on Western blots confirmed that more RelA was translocated in HLL mice compared with the p47phox-/-HLL mice after treatment with PA103 (Fig. 4C).



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 4. A and B, Western blot detection of RelA from lung nuclear protein extracts at 12 (A) and 24 h (B) after IT administration of P. aeruginosa. C, Densitometry confirmed a significant increase of RelA in lungs of HLL mice compared with p47phox-/-HLL mice at 12 and 24 h. Mean ± SEM, n = 6.

 
TNF-{alpha} is an NF-{kappa}B-dependent gene which has important functions in host defense. Hence, we measured the levels of TNF-{alpha} in BAL and lungs from HLL and p47phox-/-HLL mice after administration of P. aeruginosa using ELISA. There were significantly higher levels of TNF-{alpha} both in the BAL and lung homogenates of HLL mice compared with the p47phox-/-HLL mice (Fig. 5).



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 5. TNF-{alpha} levels from BAL and lung homogenates 24 h after IT injection of P. aeruginosa. p47phox-/-HLL mice showed significantly lower levels of TNF-{alpha} in lavage (A) and lungs (B) compared with HLL mice. *, p < 0.05. Mean ± SEM, n = 6

 
Bacterial colony counts were measured by culturing the right middle lobe of the lungs from the two groups of mice at 12 and 24 h postinfection. The p47phox-/-HLL mice showed increased bacterial colony counts as compared with the HLL mice (Fig. 6). To assess the bacterial clearance in vivo, we used XEN-5, a strain of P. aeruginosa that can be detected in vivo using BLI, because it expresses the bacterial lux operon. HLL or p47phox-/-HLL mice (n = 4) were treated with IT XEN-5 (1 x 106 CFU). At 24 h after bacterial inoculation, p47phox-/- mice showed much greater bioluminescent signal over the chest with photon counts of 532 ± 234, indicating a 5-fold greater number of viable bacteria in the lungs compared with the wild-type mice (112 ± 64) (Fig. 7). Thus, the bacterial colony counts and BLI measurement of XEN-5 indicates that p47phox-/- mice were unable to clear bacteria from the lungs compared with mice sufficient in p47phox protein.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 6. Bacterial colony counts from the right middle lobe (RML) after IT administration of P. aeruginosa. p47phox-/-HLL mice showed a significantly higher numbers of colonies than HLL mice. *, p < 0.05 compared with HLL mice at each time points. Mean ± SEM, n = 6.

 


View larger version (100K):
[in this window]
[in a new window]
 
FIGURE 7. Bioluminescence measurements of bacterial load. Representative images of labeled P. aeruginosa (XEN-5) dose of 106 in HLL and p47phox-/-HLL mice reveal a higher signal in p47phox-/-HLL compared with HLL mice at 24 h.

 
TLR4 and NADPH oxidase are required for maximal activation of NF-{kappa}B in macrophages infected with P. aeruginosa

To assess the relative contributions of TLR4 and redox signaling in phagocytes to NF-{kappa}B activation in response to P. aeruginosa, we performed studies on BMDM from TLR4-deficient or p47phox-deficient mice. TLR4 transduces the signals that lead to the production of inflammatory mediators in response to LPS via activation of NF-{kappa}B, but its role in mediating the host response to P. aeruginosa has not been clearly defined. To investigate the role of TLR4 in activation of NF-{kappa}B, we used BMDM from C3H/HeJ mice that have a functional mutation of TLR4 gene. Bone marrow cells were isolated and cultured from C3H/HeJ or BALBc mice as described above. After 6 days in culture, cells were infected with P. aeruginosa (PA103) at a multiplicity of infection (MOI) of 1 for 4 h. Cells were then washed with PBS and incubated for 24 h. NF-{kappa}B activation was detected by Western blot analysis for RelA from the nuclear extracts of the cells. RelA nuclear translocation was significantly impaired in mice with mutant TLR4 (Fig. 8).



View larger version (10K):
[in this window]
[in a new window]
 
FIGURE 8. Western blot for RelA analysis from nuclear extracts of BMDM from TLR4-/- and control BALBc (TLR4+/+) mice at baseline and after infection with P. aeruginosa (MOI = 1).

 
To identify the contribution of NADPH oxidase to NF-{kappa}B activation, BMDM were isolated and cultured from p47phox-/-HLL or HLL mice. Identical studies to those described above were performed, and luciferase activity in cell lysates was measured to determine NF-{kappa}B activation. Luciferase activity in untreated cells was similar for p47phox-/-HLL and HLL mice. After treatment with PA103, cells from HLL mice showed an 8-fold increase in luciferase activity, whereas cells from p47phox-/-HLL mice showed only a 2-fold increase over macrophages treated with PBS (Fig. 9). These data indicate that Pseudomonas activates NF-{kappa}B primarily through TLR4 in phagocytes; however, the additional effects of redox signaling are necessary for maximal activation of NF-{kappa}B.



View larger version (11K):
[in this window]
[in a new window]
 
FIGURE 9. BMDM (1 x 106 cells) were obtained from HLL and p47phox-/-HLL mice. Luciferase activity was assessed 24 h after treatment with PA 103 or vehicle (PBS). *, p < 0.05 compared with PBS treatment. **, p < 0.05 compared with all groups. Mean ± SE, n = 3 separate experiments.

 
To confirm these data, Western blot analysis for nuclear and total cellular RelA was performed in BMDM from HLL, p47phoxHLL, and TLR4-/- mice (Fig. 10A). RelA nuclear translocation was impaired in both p47phox-/- and TLR4-/- macrophages, although the total cellular RelA was similar in all the three groups. These data are also illustrated quantitatively by analysis of laser densitometry data (Fig. 10B) where we compared the ratio of RelA that was translocated to the nuclear compartment (top band) to that of total cellular RelA (bottom band).



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 10. A, Western blot analysis of nuclear (upper band) and total cellular (lower band) RelA from BMDM from HLL, p47phox-/-HLL, and TLR4-/- mice treated with PA103 (MOI of 1) or vehicle (PBS). B, Densitometry representing the percentage of RelA translocated in the nucleus.

 
Finally, we measured superoxide production by BMDM from HLL, p47phox-/-HLL, and TLR4-/- mice. BMDM from these mice were treated with P. aeruginosa, PMA, or PBS, and superoxide production was measured (Fig. 11). Both P. aeruginosa and PMA induced superoxide production by HLL macrophages, but superoxide generation was not induced in BMDM from p47phox-/-HLL mice by either treatment. In contrast, TLR4-/- macrophages were able to produce only a small increase in superoxide in response to P. aeruginosa, whereas the response to PMA was similar to HLL macrophages. These data confirm that p47phox-/-HLL macrophages have a functional defect in superoxide production in response to infection. In addition, these findings show that TLR4 is required for NADPH oxidase-dependent superoxide production following Pseudomonas infection.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 11. Superoxide measurement, shown as relative light units (RLU), in culture supernatant from BMDM from HLL, p47phox-/-HLL, and TLR4-/- mice. p47phox-/-HLL macrophages were unable to generate superoxide in response to PMA or P. aeruginosa (PA103). TLR4-/- macrophages produced abundant superoxide in response to PMA but not PA103. *, p < 0.05 compared with other PBS-treated control groups. **, p < 0.05 compared with other PA103-treated groups. Mean ± SE.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In these studies, we evaluated the role of redox signaling in the activation of NF-{kappa}B and host defense against P. aeruginosa infection. We used p47phox-deficient mice with an NF-{kappa}B luciferase reporter (p47phox-/-HLL), where luciferase activity serves as an in vivo detectable marker of NF-{kappa}B activation. p47phox-/-HLL mice showed significantly reduced luciferase activity as compared with the nondeficient HLL transgenic reporter mice following Pseudomonas infection. In comparison, infected p47phox-/-HLL mice had higher numbers of viable bacteria in the lungs than HLL mice, indicating that impaired NF-{kappa}B activation was not due to an insufficient inflammatory stimulus. Our correlative cell culture experiments, using BMDM from these mice, showed that NF-{kappa}B activation in response to treatment with P. aeruginosa is transduced through the TLR4 receptor but is also dependent on functional NADPH oxidase.

The production of superoxide is initiated by NADPH oxidase, which becomes activated upon translocation of several cytosolic proteins (p40phox, p47phox, p67phox, and the Rho family of GTPases, Rac1 or -2) to the membrane-bound complex carrying cytochrome c (gp91phox, p22phox, and Rap1a). The assembled oxidase is then able to transfer electrons to oxygen by means of its electron-carrying prosthetic group (5). The respiratory burst generated by the NADPH oxidase is critical for defending the host against invading pathogens. These host defense functions are attributed largely to direct microbicidal action of the toxic intermediates such as H2O2 and OH ions. Reeves et al. (21) showed that the production of ROS in phagocytes also facilitates the activation of neutrophil elastase and cathepsin G by liberating these bound enzymes from the matrix. ROS have been shown to be involved in signaling by activation of transcription factors (NF-{kappa}B, AP-1) and mitogen-activated protein kinases (6, 7, 22). A variety of in vitro studies have suggested that ROS act as second messengers and affect NF-{kappa}B activation (15, 23, 24). In some cells, direct treatment with oxidants activates NF-{kappa}B. In vitro treatment with antioxidants such as N-acetylcysteine or overexpression of endogenous antioxidants such as superoxide dismutase has been shown to block NF-{kappa}B activation (25, 26). The binding of NF-{kappa}B to its cognate DNA sequence is also influenced by the redox state (27). Similar studies investigating the role of ROS in activation of transcription factors in vivo are scant (28, 29, 30). In vivo, LPS induced NF-{kappa}B activation, and acute lung inflammation can be inhibited by treatment with antioxidants such as N-acetylcysteine (30). In addition, we have shown that nuclear translocation of NF-{kappa}B in the lungs is reduced in p47phox-/- mice compared with wild-type mice in models of lung inflammation induced by i.p. injection or aerosolization of Escherichia coli LPS (31). In a model of TNF-{alpha}-induced systemic inflammation, Fan et al. (32) showed that NF-{kappa}B activation and ICAM-1 expression were significantly attenuated in lungs of p47phox-/- mice compared with wild-type mice. Together, these data indicate that ROS produced by NADPH oxidase are required for maximal activation of NF-{kappa}B following a variety of inflammatory stimuli. The present study demonstrates that ROS are important for the maximal activation of NF-{kappa}B in response to P. aeruginosa infection and thus may contribute to host defense via redox signaling.

Because NADPH oxidase affects both microbicidal activity and signaling capabilities of phagocytes, it is difficult to dissect out the relative contribution of each to the antimicrobial response. Nonetheless, we found that the levels of TNF-{alpha} were significantly lower in p47phox-/- mice compared with wild type, possibly contributing to impaired host defenses in these animals. TNF-{alpha} expression is NF-{kappa}B dependent and signals activation of macrophage phagocytosis and microbicidal activity in culture. It also facilitates site-directed recruitment of phagocytic cells in vivo. Inhibition of TNF has been shown to result in decreased bacterial clearance and increased mortality in various animal models of infection (33, 34). Our studies demonstrate that NF-{kappa}B-dependent production of TNF-{alpha} is deficient in p47phox-/- mice. Thus, the altered host response in these mice in terms of decreased bacterial clearance may also be related to these deficiencies.

TLRs have been implicated in regulation of host responses to microbial products. TLR4 recognizes LPS from Gram-negative bacteria and mediates the innate immune response. The absence of NF-{kappa}B activation in response to P. aeruginosa infection in phagocyte cultures from TLR4-deficient mice indicates a critical role for TLR4. In the present study, we showed that nuclear translocation of RelA is significantly reduced in both the TLR4-deficient and NADPH oxidase-deficient macrophages. Thus, our data suggest that an intact TLR4 signaling pathway and NADPH oxidase system are necessary for maximal activation of NF-{kappa}B.

This study has important implications in understanding the role of NF-{kappa}B and redox signaling in infection and host defense mechanisms. We have shown that P. aeruginosa infection is associated with intense activation of NF-{kappa}B, and the inability of p47phox-/- mice to generate oxidative burst impairs their ability to activate NF-{kappa}B following challenge with P. aeruginosa. Thus, ROS from NADPH oxidase contribute to host defenses through direct microbicidal action and through modulation of redox-sensitive signal transduction pathways.


    Footnotes
 
1 This work was supported by the U.S. Department of Veterans Affairs and National Institutes of Health, National Heart, Lung, and Blood Institute (HL61419 and HL66196). Back

2 Address correspondence and reprint requests to Dr. Ruxana T. Sadikot, Division of Allergy, Pulmonary and Critical Care, Vanderbilt University School of Medicine, T-1217 Medical Center North, Nashville, TN 37232-2650. E-mail address: ruxana.sadikot{at}Vanderbilt.edu Back

3 Abbreviations used in this paper: ROS, reactive oxygen species; TLR, Toll-like receptor; MIP, macrophage-inflammatory protein; LTR, long terminal repeat; HLL, HIV-LTR/luciferase; BLI, bioluminescent imaging; BMDM, bone marrow-derived macrophage; IT, intratracheal; BAL, bronchoalveolar lavage; MOI, multiplicity of infection. Back

Received for publication July 9, 2003. Accepted for publication November 19, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Crouch Brewer, S., R. G. Wunderink, C. B. Jones, K. V. Leeper, Jr. 1996. Ventilator associated pneumonia due to Pseudomonas aeruginosa. Chest 109:1019.[Abstract/Free Full Text]
  2. Buret, A., A. Cripps. 1993. The immunoevasive activities of Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 148:793.[Medline]
  3. Beutler, B.. 2000. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 12:20.[Medline]
  4. Underhill, D. M., A. Ozinsky. 2002. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:103.[Medline]
  5. Baboir, B. M.. 1999. NADPH oxidase: an update. Blood 5:1464.
  6. Forman, H. J., M. Torres. 2001. Redox signaling in macrophages. Mol. Aspects Med. 22:189.[Medline]
  7. Forman, H. J., M. Torres. 2002. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166:S4.
  8. Christman, J. W., R. T. Sadikot, T. S. Blackwell. 2000. The role of nuclear factor {kappa}B in pulmonary diseases. Chest 117:1482.[Abstract/Free Full Text]
  9. Ghosh, S., M. Karin. 2002. Missing pieces in the NF-{kappa}B puzzle. Cell 109:S81.
  10. Becker, M. N., G. Diamonds, M. W. Verghese, S. H. Randell. 2000. CD14 dependent LPS induced {beta}-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275:29731.[Abstract/Free Full Text]
  11. Blackwell, T. S., F. E. Yull, C. L. Chen, A. Venkatakrishnan, T. R. Blackwell, D. J. Hicks, L. H. Lancaster, J. W. Christman, L. D. Kerr. 2000. NF-{kappa}B activation and cytokine production in a transgenic mouse model of endotoxin-induced lung inflammation. Am. J. Respir. Crit. Care Med. 162:1095.[Abstract/Free Full Text]
  12. Sadikot, R. T., E. D. Jansen, T. R. Blackwell, O. Zoia, F. Yull, J. W. Christman, T. S. Blackwell. 2001. High dose dexamethasone accentuates NF-{kappa}B activation in endotoxin treated mice. Am. J. Respir. Crit. Care Med. 164:873.[Abstract/Free Full Text]
  13. Contag, C. H., P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, D. A. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593.[Medline]
  14. Contag, C. H., S. D. Spilman, P. R. Contag, M. Oshiro, B. Eames, P. Dennery, D. K. Stevenson, D. A. Benaron. 1997. Visualizing gene expression in living animals using a bioluminescent reporter. Photochem. Photobiol. 66:523.[Medline]
  15. Li, N., M. Karin. 1999. Is NF-{kappa}B the sensor of oxidative stress?. FASEB J. 13:1137.[Abstract/Free Full Text]
  16. Kadurungamuwa, J. L., L. Sin, E. Albert, J. Yu, K. Francis, M. Deboer, M. Rubin, C. Bellinger-Kawahara, T. R. Parr, P. R. Contag. 2003. Direct continuous method for monitoring biofilm infection in a mouse model. Infect. Immun. 71:882.[Abstract/Free Full Text]
  17. Sadikot, R. T., W. Han, M. B. Everhart, O. Zoia, R. S. Peebles, E. D. Jansen, F. E. Yull, J. W. Christman, T. S. Blackwell. 2003. Selective I{kappa}B kinase expression in airway epithelium generates neutrophilic lung inflammation. J. Immunol. 170:109.
  18. Frackman, S., M. Anhalt, K. H. Nealson. 1990. Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens. J. Bacteriol. 172:5767.[Abstract/Free Full Text]
  19. Bradford, M. M.. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.[Medline]
  20. Deryckere, F., F. Gannon. 1994. A one hour minipreparation technique for extraction of DNA binding proteins from animal tissues. BioTechniques 16:405.[Medline]
  21. Reeves, E. P., H. Lu, H. Lortat Jacobs, C. G. M. Messina, S. Bolsover, G. Gabella, E. O. Potma, A. Warley, J. Roes, A. W. Segal. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416:291.[Medline]
  22. Christman, J. W., T. S. Blackwell, B. H. J. Jurlink. 2000. Redox regulation of nuclear factor {kappa}B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 10:153.[Medline]
  23. Flohe, L., R. Brigelius-Flohe, C. Saliou, M. G. Traber, L. Packer. 1997. Redox regulation of NF-{kappa}B activation. Free Radical Biol. Med. 22:1115.[Medline]
  24. Hutter, D., J. J. Greene. 2000. Influence of the cellular redox state on NF-{kappa}B regulated gene expression. J. Cell. Physiol. 183:45.[Medline]
  25. Staal, F. J., M. Roederer, L. A. Herzenberg, L. A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor {kappa}B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:9943.[Abstract/Free Full Text]
  26. Ivanov, V., M. Merkenschlager, R. Ceredig. 1993. Antioxidant treatment of thymic organ cultures decreases NF-{kappa}B and TCF1({alpha}) transcription factor activation and inhibits {alpha}{beta} T cell development. J. Immunol. 151:4694.[Abstract]
  27. Schreck, R., K. Albermann, P. A. Baeurle. 1992. NF-{kappa}B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Res. Commun. 17:221.[Medline]
  28. Gao, X. P., T. J. Standiford, A. Rahman, M. Newstead, S. M. Holland, M. C. Dinaur, Q. H. Liu, A. B. Malik. 2002. Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice. J. Immunol. 168:3974.[Abstract/Free Full Text]
  29. Kono, H., I. Rusyn, M. Yin, E. Gabele, S. Yamashina, A. Dikalova, M. B. Kadiska, H. D. Conor, R. P. Mason, B. H. Segal, et al 2000. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. 106:867.[Medline]
  30. Blackwell, T. S., T. R. Blackwell, E. P. Holden, B. W. Christman, J. W. Christman. 1996. In vivo antioxidant treatment suppresses NF-{kappa}B and neutrophilic lung inflammation. J. Immunol. 157:1630.[Abstract]
  31. Koay, M. A., J. W. Christman, B. H. Segal, A. Venkatakrishnan, T. R. Blackwell, S. M. Holland, T. S. Blackwell. 2001. Impaired pulmonary NF-{kappa}B activation in response to lipopolysaccharide in NADPH oxidase-deficient mice. Infect. Immun. 69:5991.[Abstract/Free Full Text]
  32. Fan, J., R. S. Frey, A. Rahman, A. B. Malik. 2002. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-{alpha}-induced NF- {kappa}B activation and intercellular adhesion molecule-1 expression in endothelial cells. J. Biol. Chem. 277:3404.[Abstract/Free Full Text]
  33. Standiford, T. J., J. M. Wilkowski, T. H. Sisson, N. Hattori, B. Mehrad, K. A. Bucknell, T. A. Moore. 1999. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine Gram-negative pneumonia. Hum. Gene Ther. 10:899.[Medline]
  34. Chen, G. H., R. C. Reddy, M. W. Newstead, K. Tateda, B. L. Kyasapura, T. J. Standiford. 2000. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J. Immunol. 165:6496.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
V. M. Weis
Cellular mechanisms of Cnidarian bleaching: stress causes the collapse of symbiosis
J. Exp. Biol., October 1, 2008; 211(19): 3059 - 3066.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhang, X. Li, A. Carpinteiro, and E. Gulbins
Acid Sphingomyelinase Amplifies Redox Signaling in Pseudomonas aeruginosa-Induced Macrophage Apoptosis
J. Immunol., September 15, 2008; 181(6): 4247 - 4254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. M. Marriott, L. E. Jackson, T. S. Wilkinson, A. J. Simpson, T. J. Mitchell, D. J. Buttle, S. S. Cross, P. G. Ince, P. G. Hellewell, M. K. B. Whyte, et al.
Reactive Oxygen Species Regulate Neutrophil Recruitment and Survival in Pneumococcal Pneumonia
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 887 - 895.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
G. T. Stathopoulos, T. P. Sherrill, W. Han, R. T. Sadikot, F. E. Yull, T. S. Blackwell, and B. Fingleton
Host Nuclear Factor-{kappa}B Activation Potentiates Lung Cancer Metastasis
Mol. Cancer Res., March 1, 2008; 6(3): 364 - 371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. P. Mizgerd and S. J. Skerrett
Animal models of human pneumonia
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L387 - L398.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Joo, M. Kwon, R. T. Sadikot, P. J. Kingsley, L. J. Marnett, T. S. Blackwell, R. S. Peebles Jr, Y. Urade, and J. W. Christman
Induction and Function of Lipocalin Prostaglandin D Synthase in Host Immunity
J. Immunol., August 15, 2007; 179(4): 2565 - 2575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. Mathew, G. Y. Park, H. Cao, A. C. Azim, X. Wang, R. B. Van Breemen, R. T. Sadikot, and J. W. Christman
Inhibitory {kappa}B Kinase 2 Activates Airway Epithelial Cells to Stimulate Bone Marrow Macrophages
Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 562 - 572.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Koff, M. X. G. Shao, S. Kim, I. F. Ueki, and J. A. Nadel
Pseudomonas Lipopolysaccharide Accelerates Wound Repair via Activation of a Novel Epithelial Cell Signaling Cascade
J. Immunol., December 15, 2006; 177(12): 8693 - 8700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. M. Vogel, J. Orrington-Myers, M. Broman, and A. B. Malik
De novo ICAM-1 synthesis in the mouse lung: model of assessment of protein expression in lungs
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L496 - L501.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
O. Dehus, T. Hartung, and C. Hermann
Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay
Innate Immunity, June 1, 2006; 12(3): 171 - 180.
[Abstract] [PDF]


Home page
J. Immunol.Home page
V. Sancho-Shimizu and D. Malo
Sequencing, Expression, and Functional Analyses Support the Candidacy of Ncf2 in Susceptibility to Salmonella Typhimurium Infection in Wild-Derived Mice.
J. Immunol., June 1, 2006; 176(11): 6954 - 6961.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Everhart, W. Han, T. P. Sherrill, M. Arutiunov, V. V. Polosukhin, J. R. Burke, R. T. Sadikot, J. W. Christman, F. E. Yull, and T. S. Blackwell
Duration and Intensity of NF-{kappa}B Activity Determine the Severity of Endotoxin-Induced Acute Lung Injury.
J. Immunol., April 15, 2006; 176(8): 4995 - 5005.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. T. Sadikot and T. S. Blackwell
Bioluminescence Imaging
Proceedings of the ATS, December 1, 2005; 2(6): 537 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. R. Sheppard, M. R. Kelher, E. E. Moore, N. J. D. McLaughlin, A. Banerjee, and C. C. Silliman
Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation
J. Leukoc. Biol., November 1, 2005; 78(5): 1025 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. M. Siore, R. E. Parker, A. A. Stecenko, C. Cuppels, M. McKean, B. W. Christman, R. Cruz-Gervis, and K. L. Brigham
Endotoxin-induced acute lung injury requires interaction with the liver
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L769 - L776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Musiek, L. Gao, G. L. Milne, W. Han, M. B. Everhart, D. Wang, M. G. Backlund, R. N. DuBois, G. Zanoni, G. Vidari, et al.
Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages
J. Biol. Chem., October 21, 2005; 280(42): 35562 - 35570.
[Abstract] [Full Text] [PDF]